Insider Transactions in Q1 2022 at Entasis Therapeutics Holdings Inc. (ETTX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2022
|
Kristie Ann Wagner VP, Principal Fin & Acct Off |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+11.05%
|
-
|
|
Jan 18
2022
|
Anna Diaz Triola Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+50.0%
|
-
|
|
Jan 18
2022
|
David Altarac Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+42.72%
|
-
|
|
Jan 18
2022
|
David C Hastings Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+35.71%
|
-
|
|
Jan 18
2022
|
David D. Meek Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+35.71%
|
-
|
|
Jan 18
2022
|
Elizabeth M Keiley General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+42.72%
|
-
|
|
Jan 18
2022
|
Heather A. Berger Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+35.71%
|
-
|
|
Jan 18
2022
|
Howard Mayer Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+35.71%
|
-
|
|
Jan 18
2022
|
John Patrick Mueller Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+42.79%
|
-
|
|
Jan 18
2022
|
Manoussos Perros President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+18.95%
|
-
|
|
Jan 18
2022
|
Matthew Ronsheim Chief of Pharma Sciences & MFG |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+42.72%
|
-
|
|
Jan 18
2022
|
Michael Gutch Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+42.72%
|
-
|
|
Jan 18
2022
|
Ruben Tommasi Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+39.73%
|
-
|